137 related articles for article (PubMed ID: 38614966)
21. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
22. Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy.
Goto A; Sukawa Y; Igarashi H; Onodera K; Aoki Y; Suzuki K; Yonezawa K; Yawata A; Kobayashi T; Kaneto H; Shimizu H; Wakasugi H; Matsunaga Y; Itoh M; Okuda H; Arimura Y; Shinomura Y
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1461-6. PubMed ID: 21945893
[TBL] [Abstract][Full Text] [Related]
23. Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.
Niegisch G; Grimm MO; Hardtstock F; Krieger J; Starry A; Osowski U; Guenther S; Deiters B; Maywald U; Wilke T; Kearney M
Future Oncol; 2024 Apr; ():. PubMed ID: 38647011
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
Yamaguchi K; Sawaki A; Doi T; Satoh T; Yamada Y; Omuro Y; Nishina T; Boku N; Chin K; Hamamoto Y; Takiuchi H; Komatsu Y; Saji S; Koizumi W; Miyata Y; Sato A; Baba E; Tamura T; Abe T; Ohtsu A
Gastric Cancer; 2013 Apr; 16(2):175-82. PubMed ID: 22782463
[TBL] [Abstract][Full Text] [Related]
25. Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.
Black CM; Hanna GJ; Wang L; Ramakrishnan K; Goto D; Turzhitsky V; Hair GM
Front Oncol; 2023; 13():1160144. PubMed ID: 37284189
[TBL] [Abstract][Full Text] [Related]
26. Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database.
Borchmann P; Heger JM; Mahlich J; Papadimitrious MS; Riou S; Werner B
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7091-7101. PubMed ID: 36871091
[TBL] [Abstract][Full Text] [Related]
27. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
Groth A; Wilke T; Borghs S; Gille P; Joeres L
Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
[No Abstract] [Full Text] [Related]
28. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
[TBL] [Abstract][Full Text] [Related]
29. Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer.
Gómez-Ulloa D; Amonkar M; Kothari S; Cheung WY; Chau I; Zalcberg JR; Lara Suriñach N; Falcone A
BMC Gastroenterol; 2020 May; 20(1):133. PubMed ID: 32370803
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and consequences of missed gastric cancer: A multicentric cohort study.
Hernanz N; Rodríguez de Santiago E; Marcos Prieto HM; Jorge Turrión MÁ; Barreiro Alonso E; Rodríguez Escaja C; Jiménez Jurado A; Sierra M; Pérez Valle I; Volpato N; García Prada M; Nuñez-Gómez L; Ríos-León R; Castaño García A; García de Paredes AG; Aicart M; Caminoa A; Peñas Parcía B; Vázquez-Sequeiros E; Albillos A
Dig Liver Dis; 2019 Jun; 51(6):894-900. PubMed ID: 30898522
[TBL] [Abstract][Full Text] [Related]
31. Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study.
Tjulandin SA; Tryakin AA; Besova NS; Sholokhova E; Ivanova JI; Cheng WY; Schmerold LM; Thompson-Leduc P; Novick D
J Drug Assess; 2019; 8(1):150-158. PubMed ID: 31656688
[No Abstract] [Full Text] [Related]
32. Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA.
Barzi A; Lin F; Song J; Lam C; Nie X; Noman A; Kwong WJ
Drugs Real World Outcomes; 2023 Sep; 10(3):395-404. PubMed ID: 37540381
[TBL] [Abstract][Full Text] [Related]
33. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer.
Hannarici Z; Yılmaz A; Buyukbayram ME; Turhan A; Çağlar AA; Bilici M; Tekin SB
Future Oncol; 2023 Feb; 19(4):315-325. PubMed ID: 37125596
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of metachronous gastric cancers after surgical treatment for esophageal squamous cell carcinoma.
Kim HJ; Lee JH; Moon TG; Lee JS; Kim YH; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Shim YM
Hepatogastroenterology; 2008; 55(82-83):457-62. PubMed ID: 18613387
[TBL] [Abstract][Full Text] [Related]
35. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
Norden AD; Korytowsky B; You M; Kim Le T; Dastani H; Bobiak S; Singh P
J Manag Care Spec Pharm; 2019 Apr; 25(4):428-436. PubMed ID: 30917077
[TBL] [Abstract][Full Text] [Related]
36. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection.
Abe S; Oda I; Suzuki H; Nonaka S; Yoshinaga S; Nakajima T; Sekiguchi M; Mori G; Taniguchi H; Sekine S; Katai H; Saito Y
Endoscopy; 2015 Dec; 47(12):1113-8. PubMed ID: 26165734
[TBL] [Abstract][Full Text] [Related]
37. Identification of optimal primary tumor resection candidates for metastatic gastric cancer: Nomograms based on propensity score matching.
Li Z; Zheng H; Zhao Z; Chen G; Wang Z; Amin B; Zhang N
Cancer Med; 2023 Jun; 12(12):13063-13075. PubMed ID: 37096953
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of patients with locally advanced or metastatic gastric cancer in Argentina.
Novick D; Mendez G; Carballido M; Rizzo M; O'Connor JM; Castillo J; Lee Kay Pen D; Siddi S; Rodante D; Moneta MV; Haro JM
Medwave; 2019 Sep; 19(8):e7692. PubMed ID: 31596840
[TBL] [Abstract][Full Text] [Related]
39. HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.
Haffner I; Schierle K; Raimúndez E; Geier B; Maier D; Hasenauer J; Luber B; Walch A; Kolbe K; Riera Knorrenschild J; Kretzschmar A; Rau B; Fischer von Weikersthal L; Ahlborn M; Siegler G; Fuxius S; Decker T; Wittekind C; Lordick F
J Clin Oncol; 2021 May; 39(13):1468-1478. PubMed ID: 33764808
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic study of early-stage mucinous gastric carcinoma.
Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
